FDA Inspection 1266243 — Grifols Biomat USA, Inc.
The FDA completed an inspection of Grifols Biomat USA, Inc. on March 24, 2025 in Fairless Hills, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fairless Hills, PA (United States)